Ertugliflozin is a medication that belongs to a class of drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. It is used in the treatment of type 2 diabetes to help lower blood sugar levels in adults.

This medication works by blocking the reabsorption of glucose in the kidneys, allowing excess glucose to be excreted in the urine. By doing so, Ertugliflozin helps to reduce blood sugar levels and improve glycemic control in patients with type 2 diabetes.

It is important to note that Ertugliflozin should not be used to treat type 1 diabetes or diabetic ketoacidosis. It is typically prescribed as part of a comprehensive treatment plan that includes diet, exercise, and other medications to manage diabetes.

As with any medication, there are potential side effects associated with Ertugliflozin. These may include urinary tract infections, increased urination, dehydration, and low blood pressure. It is important to discuss any concerns or potential side effects with your healthcare provider before starting this medication.

Overall, Ertugliflozin can be a valuable tool in the management of type 2 diabetes when used as directed by a healthcare professional. It is important to follow your healthcare provider’s instructions and monitor your blood sugar levels regularly while taking this medication. If you have any questions or concerns about Ertugliflozin, do not hesitate to reach out to your healthcare provider for guidance.